These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18638850)

  • 1. Immunobiology of malignant gliomas.
    Tada M; de Tribolet N
    J Clin Neurosci; 1996 Apr; 3(2):102-13. PubMed ID: 18638850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human glioma immunobiology in vitro: implications for immunogene therapy.
    Parney IF; Farr-Jones MA; Chang LJ; Petruk KC
    Neurosurgery; 2000 May; 46(5):1169-77; discussion 1177-8. PubMed ID: 10807250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant glioma modulation of immune function: relative contribution of different soluble factors.
    Couldwell WT; Dore-Duffy P; Apuzzo ML; Antel JP
    J Neuroimmunol; 1991 Aug; 33(2):89-96. PubMed ID: 2066398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The immunosuppressive microenvironment of malignant gliomas].
    Borisov KE; Sakaeva DD
    Arkh Patol; 2015; 77(6):54-63. PubMed ID: 26841651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunobiology of the normal and tumor astrocyte].
    Pulver M; Zuber P; de Tribolet N
    Rev Neurol (Paris); 1987; 143(11):711-21. PubMed ID: 3324264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant glioma.
    Ochs K; Sahm F; Opitz CA; Lanz TV; Oezen I; Couraud PO; von Deimling A; Wick W; Platten M
    J Neuroimmunol; 2013 Dec; 265(1-2):106-16. PubMed ID: 24090655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleiotrophin, an angiogenic and mitogenic growth factor, is expressed in human gliomas.
    Mentlein R; Held-Feindt J
    J Neurochem; 2002 Nov; 83(4):747-53. PubMed ID: 12421346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptophan-2,3-dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor-4.
    Ochs K; Ott M; Rauschenbach KJ; Deumelandt K; Sahm F; Opitz CA; von Deimling A; Wick W; Platten M
    J Neurochem; 2016 Mar; 136(6):1142-1154. PubMed ID: 26708701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel anti-angiogenic therapies for malignant gliomas.
    Norden AD; Drappatz J; Wen PY
    Lancet Neurol; 2008 Dec; 7(12):1152-60. PubMed ID: 19007739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine and paracrine regulation by cytokines and growth factors in melanoma.
    Lázár-Molnár E; Hegyesi H; Tóth S; Falus A
    Cytokine; 2000 Jun; 12(6):547-54. PubMed ID: 10843728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro studies of cytokine-mediated interactions between malignant glioma and autologous peripheral blood mononuclear cells.
    Jachimczak P; Schwulera U; Bogdahn U
    J Neurosurg; 1994 Oct; 81(4):579-86. PubMed ID: 7931592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor triggered dendritic cell maturation and IL-12 secretion are necessary to overcome T-cell inhibition by glioma-associated TGF-beta2.
    Grauer O; Pöschl P; Lohmeier A; Adema GJ; Bogdahn U
    J Neurooncol; 2007 Apr; 82(2):151-61. PubMed ID: 17106649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression.
    Mittelbronn M; Platten M; Zeiner P; Dombrowski Y; Frank B; Zachskorn C; Harter PN; Weller M; Wischhusen J
    Acta Neuropathol; 2011 Sep; 122(3):353-65. PubMed ID: 21773885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant glioma-derived soluble factors regulate proliferation of normal adult human astrocytes.
    Couldwell WT; Fraser G; De Vellis G; Antel JP; Villemure JG; Yong VW
    J Neuropathol Exp Neurol; 1992 Sep; 51(5):506-13. PubMed ID: 1517771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin B receptor promotes the proliferation and immune escape of malignant gliomas.
    Pan DS; Feng SZ; Cao P; Li JJ
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1230-1235. PubMed ID: 28841806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of heparin-binding growth-associated molecule in malignant glioma cells.
    Zhang L; Mabuchi T; Satoh E; Maeda S; Nukui H; Naganuma H
    Neurol Med Chir (Tokyo); 2004 Dec; 44(12):637-43; discussion 644-5. PubMed ID: 15684595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells.
    Moriyama T; Kataoka H; Hamasuna R; Yokogami K; Uehara H; Kawano H; Goya T; Tsubouchi H; Koono M; Wakisaka S
    Biochem Biophys Res Commun; 1998 Aug; 249(1):73-7. PubMed ID: 9705834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
    Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
    Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ detection of transforming growth factor-beta mRNA in experimental rat glioma and reactive glial cells.
    Kiefer R; Supler ML; Toyka KV; Streit WJ
    Neurosci Lett; 1994 Jan; 166(2):161-4. PubMed ID: 8177493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.